Researchers continue to excited about the medication , a groundbreaking dual compound showing significant outcomes in early trials for weight loss . It acts by targeting both systems: GLP-1 and GIP, that , when stimulated, assist influence appetite and improve energy expenditure retatrutide uk . Preliminary reports demonstrate noteworthy size manag